PRECLINICAL CRO SERVICES FOR DRUGS TARGETING METABOLIC DISORDERS
Physiogenex provides preclinical in vivo and ex vivo CRO services with more than 15 years of expertise in evaluating drugs targeting metabolic disorders such as obesity, diabetes, NASH, fibrosis, diabetic nephropathy, cardiovascular complications, dyslipidemia and atherosclerosis.
We develop in-house and gold standard preclinical models in our cutting-edge facilities near Toulouse, France.
Along with our preclinical CRO services, we offer consulting services adapted to the specific needs of our clients. Our metabolic diseases experts offer their many years of experience in drug development to help you design and run efficient and cost-effective studies to shorten your product’s time to market.
STATE OF THE ART CRO FACILITIES
Physiogenex is located near Toulouse (France) in brand new facilities . Our technical platform is equipped with all appropriate devices to ensure high quality CRO services and reliable study results to our clients.
High success rate customer satisfaction in 2021: 97.5%
When is your turn?
THEY TRUST US
We work with more than 100 biopharmaceutical, nutraceutical and agrifood companies
LATEST NEWS ABOUT PHYSIOGENEX
Physiogenex to exhibit at booth#51 and present a new DIO NASH mouse study at the ILC-EASL 2022 in London, UK on June the 25th, 2022
Physiogenex will be exhibiting at booth#51 and presenting a new DIO-NASH mouse study (abstract#258) at the ILC-EASL in London, UK, on June 25th, 2022. The...
Physiogenex to present the effects of clinical benchmarks in its obese NASH hamster model at the Keystone Symposia “Tissue Fibrosis and Repair”, June 12-16, Keystone, CO, USA
Physiogenex will be presenting the effects of clinical benchmarks in its innovative obese NASH hamster model on June the 13th, 2022 at the Keystone Symposia...
Physiogenex to present a new DIO NASH mouse study at the American Diabetes Association 2022 in New Orleans, LA, USA on June the 6th, 2022
Physiogenex will be presenting a new DIO-NASH mouse study at the 82nd Scientific Sessions of the American Diabetes Association in New Orleans, LA, USA, June...